|
| |
medigene psoriasis Pages on BioPortfolio:
BioPortfolio - MediGene AG
BACKGROUND: The dogma in psoriasis is that due to pathogen-induced... 4th February, 2006, Medigene AG, Lochhamerstrasse 11, 82152 Martinsried, Germany.
...
http://www.bioportfolio.com/biocorporate/6855-MediGene_AG.ht...
|
Biotechnology News Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=ne...
|
Phase Forward Partners with Relsys International Sound Medical ...
MediGene. AG Vaccine. malignant melanoma. Phase I/II initiated. 49-89-8956-3220. EntreMed/Aventis ... achieved Psoriasis Area and Severity Index ...
http://www.bioportfolio.com/cgi-bin/acatalog/cww-smaller.pdf...
|
BioPortfolio - Galderma - Profile
protein 5) in psoriatic epidermis. The calmodulin-like skin protein ... MediGene Spins Out mTCR Programme - Independent Company Immunocore Limited Founded ...
http://www.bioportfolio.com/biocorporate/4281-Galderma.pdf...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - MediGene AG - Profile
BACKGROUND: The dogma in psoriasis is that due to pathogen-induced...4th February, 2006. Medigene AG, Lochhamerstrasse 11, 82152 Martinsried, Germany.
...
http://www.bioportfolio.com/biocorporate/6855-MediGene+AG.pd...
|
MediGene AG Sells Licensee Rights to the Drug Oracea(R) to ...
31 Jul 2008 ... MediGene had acquired the European rights to the drug from the US ... psoriasis & steroid-responsive dermatoses, pigmentary disorders, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=105215...
|
A new therapeutic approach to treat psoriasis by i...[Br J ...
Medigene AG, Lochhamerstrasse 11, 82152 Martinsried, Germany. BACKGROUND: The dogma in psoriasis is that due to pathogen-induced inflammatory responses, ...
http://www.ncbi.nlm.nih.gov/pubmed/16225603...
|
Deal Highlights
psoriasis and rheumatoid arthritis. AnGes has retained an. option to copromote products in the .... MediGene AG and Celltrion Inc have signed a memorandum ...
http://www.biomedcentral.com/content/pdf/cd-862945.pdf...
|
Drug Treatments for Skin Disease Introduced in 2006
20 Jul 2007 ... Green Tea ExtractPolyphenon® E Ointment 15%MediGene AG/ Bradley, Approved for the ... Originally indicated for plaque-type psoriasis. US FDA ...
http://www.medscape.com/viewarticle/559081...
|
Patent alert
and inflammatory skin disorders such as psoriasis, atopic ..... developed, under license, by MediGene for the treatment of. congestive heart failure. ...
http://www.biomedcentral.com/content/pdf/cd-417734.pdf...
|
BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
15 Jun 2007 ... MediGene AG (DX:MDG): RhuDex(TM) to be Examined in Further Laboratory ... in Rheumatoid Arthritis and Psoriasis Patients 6/18/2008 More. ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...
|
Phase Forward Partners with Relsys International Sound Medical ...
MediGene. AG Vaccine. malignant melanoma. Phase I/II initiated. 49-89-8956-3220. EntreMed/Aventis ... achieved Psoriasis Area and Severity Index ...
http://www.bioportfolio.com/cgi-bin/acatalog/cww-smaller.pdf...
|
Molecular Understanding and Modern Application of Traditional ...
... psoriasis, diabetic neuropathy, and postherpetic neuralgia (Table 1), .... Only in 2006 was the first such drug approved: Polyphenon E (MediGene), ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=25...
|
BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
Skin Damage From Sun Rare With Psoriasis 7/21/2004 More. ... MediGene AG (DX:MDG ) Decides On Extension Of Clinical Development Of Polyphenon E Ointment To ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...
|
|
